Sirona Life Sciences Private Limited
About Sirona Life Sciences Private Limited
Data last updated:
Sirona Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2019PTC133995.
The company has an authorised share capital of ₹1.99 Cr and a paid-up capital of ₹1.55 Cr. It is led by directors Satya Srinivas Uppalapati and Sandeep Gokaraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C 21/A Road No. 9 Film Nagar Jubilee Hilss, Hyderabad, Telangana, India – 500096.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.72 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹53.97 Lakh (net margin -31.4%) and EBITDA of -₹17.74 Lakh (EBITDA margin -10.3%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC 21/A Road No. 9 Film Nagar Jubilee Hilss, Hyderabad, Telangana, India – 500096
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sirona Life Sciences Private Limited
The main business activity of Sirona Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sirona Life Sciences Private Limited FY 2025 filings available
Sirona Life Sciences Private Limited reported revenue of ₹1.72 Cr (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sirona Life Sciences Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over three years, including a 18% fall in the latest year. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sirona Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹17.74 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹53.97 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sirona Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -31.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sirona Life Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sirona Life Sciences Private Limited
Sirona Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Srinivas Uppalapati | Director | 10 Jul 2019 | 7 Years 3 Months | Current |
| Sandeep Gokaraju Also directs: Tyche Industries Limited, Sreeven Pharma Private Limited | Director | 10 Jul 2019 | 7 Years 3 Months | Current |
Peer Comparison of Sirona Life Sciences Private Limited
Sirona Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cro Splendid Lab Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Pune, Maharashtra, India |
| Newedge Research and Development Private Limited | ₹1.83 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Juntosvida Private Limited | ₹1.79 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Navi Mumbai, Maharashtra, India |
| Institute of Minimally Invasive Surgery Research Pvt.Ltd. | ₹1.78 Cr (FY 2025) | •••• | •••• | 78.0% | •••• | Kolkata, West Bengal, India |
| St Johns Health Innovation Foundation | ₹1.74 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Bengaluru, Karnataka, India |
| Sirona Life Sciences Private Limited this company | ₹1.72 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Gaametech Private Limited | ₹1.71 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Kompally, Secunderabad, Telangana, India |
| Growth Pharmaceutical Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Bhopal, Madhya Pradesh, India |
| Steerlife India Private Limited | ₹1.68 Cr (FY 2024) | •••• | •••• | -70.0% | •••• | Bangalore, Karnataka, India |
| Formulogic Pharma Private Limited | ₹1.67 Cr (FY 2025) | •••• | •••• | 123.0% | •••• | Bangalore, Karnataka, India |
| Redlotus Pharmtech Private Limited | ₹1.67 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Panvel, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Sirona Life Sciences by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Sirona Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2019 | Hdfc Bank Limited | ₹3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sirona Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Sirona Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sirona Life Sciences Private Limited
Sirona Life Sciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sandeep Gokaraju was appointed as Director on 10 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for Sirona Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sirona Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sirona Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sirona Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sirona Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirona Life Sciences Private Limited
Sirona Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 July 2019 (7+ years old) and is registered under CIN U24290TG2019PTC133995.
Sirona Life Sciences reported revenue of ₹1.72 Cr for FY 2024 (down 18% YoY).
Sirona Life Sciences has 2 current directors:
- Satya Srinivas Uppalapati - Director
- Sandeep Gokaraju - Director
Sirona Life Sciences reported a net loss of ₹53.97 Lakh (net margin -31.4%) and EBITDA of -₹17.74 Lakh (EBITDA margin -10.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sirona Life Sciences is -4% over three years. In the latest year (FY 2024) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Sirona Life Sciences is U24290TG2019PTC133995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sirona Life Sciences was incorporated on 10 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sirona Life Sciences by revenue are Cro Splendid Lab Private Limited, Newedge Research and Development Private Limited, Juntosvida Private Limited, Institute of Minimally Invasive Surgery Research Pvt.Ltd, St Johns Health Innovation Foundation and 5 more, all in the Pharma industry (Contract Research).
Sandeep Gokaraju was appointed as Director on 10 Jul 2019. Satya Srinivas Uppalapati was appointed as Director on 10 Jul 2019.
The registered office of Sirona Life Sciences is at C 21A Road No. 9 Film Nagar Jubilee Hilss, Hyderabad, Telangana, India – 500096.
Sirona Life Sciences has an authorised share capital of ₹1.99 Cr and a paid-up capital of ₹1.55 Cr.